CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of ...
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced that the U.S. Food and ...
Neurotech’s Encelto is surgically implanted and delivers genetically modified cell therapy to the eye Neurotech Pharmaceuticals Inc.’s research efforts are paying off. The biotech company, focused on ...
Company reports continued clinical adoption, expanding reimbursement coverage, and established commercial manufacturing capacity Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results